FLT3 and acute myeloid leukemia: With its highly specific tool enzyme, ERA reduces mismatches and test error rates significantly, rendering it applicable for detecting various genes such as the drug resistance gene FLT3-F691 in acute myeloid leukemia (AML), significantly improving AML diagnosis and treatment (Liu et al., 2021b).